Regenerative Medicine Market by Product (Stem Cell Therapy {Autologous, Allogenic}, Tissue Engineering {Scaffold, Hydrogels}, Gene Therapy, Others), By Application (Regenerative medicine {Oncology, Dermatology, Musculoskeletal, Neurology, Cardiovascular, Wound healing, Ophthalmology, Others} Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles and Market Forecast, 2025 – 2035

Published Date: Sep 2024 | Report ID: MI1022 | 220 Pages

Report Summary Table of Contents Segmentation FAQ Request Free Sample Report

Report Coverage:

By Product

  • Stem Cell Therapy
    • Autologous
    • Allogenic
  • Tissue Engineering
    • Scaffold
    • Hydrogels
  • Gene Therapy
  • Others

By Application

  • Oncology
  • Dermatology
  • Musculoskeletal
  • Neurology
  • Cardiovascular
  • Wound healing
  • Ophthalmology
  • Others

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa

List of Companies

  • Novartis AG
  • Amgen
  • Bristol Myers Squibb
  • GlaxoSmithKline plc
  • TERUMO BCT
  • Smith and Nephew
  • Bluebird Bio
  • Gilead Sciences, Inc.
  • Sarepta Therapeutics
  • Takeda Pharmaceutical Company Limited
  • Medtronic plc
  • Organogenesis Inc.
  • Anterogen
  • Biosolutions
  • Avita Medical
  • Integralife
  • Mesoblast
  • Sibiono GeneTech Co. Ltd

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.

Request Bundle Pricing